Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
:JYNT
JYNT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.10 - $17.82
Previous CloseN/A
Volume11.07K
Average Volume (3M)33.26K
Market Cap
$172.76M
Enterprise Value$158.59M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Mar 13, 2025EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding14,983,609
10 Day Avg. Volume25,328
30 Day Avg. Volume33,262
Standard Deviation0.17
R-Squared0.25
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.42
Price to Cash Flow (P/CF)12.40
P/FCF Ratio13.40
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.48
Enterprise Value/Ebitda45.14
Forecast
1Y Price Target
$20.00Price Target Upside74.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Joint News
PremiumCompany Announcements
The Joint Corp. Reports Mixed Q3 2024 Results
PremiumCompany Announcements
Joint Corp. Reports Revenue Growth Amid Strategic Changes
PremiumCompany Announcements
Joint Announces Leadership Change and New CEO Appointment
---
Bulls Say, Bears Say
Bulls Say
Digital InnovationJYNT introduced digital appointment scheduling and check-in capabilities across 500 locations, which generated positive patient feedback.
Financial HealthAt quarter-end, JYNT had $17.5M in cash and no debt.
Bears Say
Guidance RevisionThe company lowered 2024 sales and clinic opening guidance, reflecting management's expectation of continued softness in patient demand through 4Q24.
Industry ChallengesDespite reporting a slight y/y improvement in 3Q24 revenue and announcing signs of a rebound in patient demand back in July, industry headwinds persisted throughout 3Q24 and are likely to continue.
Operational UncertaintyThe potential sale, relocation, or closure of company-owned clinics creates uncertainty.
---
Ownership Overview
2.16% Insiders
13.23% Mutual Funds
41.13% Other Institutional Investors
34.39% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
JYNT FAQ
What was Joint Corp’s price range in the past 12 months?
Joint Corp lowest stock price was $9.10 and its highest was $17.82 in the past 12 months.
What is Joint Corp’s market cap?
Joint Corp’s market cap is $172.76M.
When is Joint Corp’s upcoming earnings report date?
Joint Corp’s upcoming earnings report date is Mar 13, 2025 which is in 20 days.
How were Joint Corp’s earnings last quarter?
Joint Corp released its earnings results on Nov 07, 2024. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of $0.008 by -$0.218.
Is Joint Corp overvalued?
According to Wall Street analysts Joint Corp’s price is currently Undervalued.
Does Joint Corp pay dividends?
Joint Corp does not currently pay dividends.
What is Joint Corp’s EPS estimate?
Joint Corp’s EPS estimate is 0.01.
How many shares outstanding does Joint Corp have?
Joint Corp has 14,983,609 shares outstanding.
What happened to Joint Corp’s price movement after its last earnings report?
Joint Corp reported an EPS of -$0.21 in its last earnings report, missing expectations of $0.008. Following the earnings report the stock price went down -2.273%.
Which hedge fund is a major shareholder of Joint Corp?
Currently, no hedge funds are holding shares in JYNT
---
Joint Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.00 (74.67% Upside)
$20.00 (74.67% Upside)
Blogger Sentiment
Neutral
JYNT Sentiment 50%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.39%
12-Months-Change
Fundamentals
Return on Equity
-60.51%
Trailing 12-Months
Asset Growth
-19.25%
Trailing 12-Months
Company Description
Joint Corp
The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
---
JYNT Company Deck
---
JYNT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of achievements and challenges. While there were strong performances in system-wide sales and strategic initiatives like refranchising and digital improvements, these were countered by financial setbacks such as decreased net income and revised growth projections due to consumer headwinds.Read More>---
JYNT Stock 12 Month Forecast
Average Price Target
$20.00
▲(74.67% Upside)
Technical Analysis
Best Analysts Covering JYNT
1 Year
1 Year Success Rate
11/18 ratings generated profit
1 Year Average Return
+117.21%
reiterated a buy rating 7 months ago
Copying Jeff Van Sinderen's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +117.21% per trade.
---